T2 Biosystms company info

What does T2 Biosystms do?
T2 Biosystems (NASDAQ:TTOO) is a company focused on innovative diagnostic solutions for critical health conditions. Their operations mainly revolve around the development and commercialization of diagnostic products that aim to save lives and improve patient outcomes by providing faster, more accurate detection of sepsis, Lyme disease, and other severe infections. Leveraging their proprietary T2 Magnetic Resonance technology, T2 Biosystems is dedicated to addressing challenges in healthcare where rapid and precise diagnostics are crucial. The company's objectives include expanding their product range, enhancing diagnostic efficiency, and making their technology accessible to a broader audience globally, ensuring that healthcare providers can make informed decisions swiftly, ultimately improving patient care.
T2 Biosystms company media
Company Snapshot

Is T2 Biosystms a public or private company?

key
Ownership
Public

How many people does T2 Biosystms employ?

people
Employees
113

What sector is T2 Biosystms in?

pie chart
Sector
Health Care

Where is the head office for T2 Biosystms?

location pin
Head Office
Lexington, United States

What year was T2 Biosystms founded?

founded flag
Year Founded
2006
What does T2 Biosystms specialise in?
/Diagnostic Solutions /Bacterial Identification /Susceptibility Tests /Rapid Detection /Healthcare Technology /Infectious Diseases

What are the products and/or services of T2 Biosystms?

Overview of T2 Biosystms offerings
T2Dx Instrument, a fully automated device for rapid detection of pathogens and antibiotic resistance genes directly from whole blood samples.
T2Bacteria Panel, identifies critical sepsis-causing bacteria directly from blood, avoiding culture delays.
T2Candida Panel, detects five Candida species directly from blood, aiding in the rapid diagnosis of candidemia.
T2Resistance Panel, identifies genetic markers of antibiotic resistance, facilitating targeted therapy choices.
T2SARS-CoV-2 Panel, a molecular diagnostic test for the qualitative detection of SARS-CoV-2.
T2Lyme Panel, an advanced diagnostic test for the detection of Lyme disease-causing bacteria.

Who is in the executive team of T2 Biosystms?

T2 Biosystms leadership team
  • Mr. John J. Sperzel III, B.Sc.
    Mr. John J. Sperzel III, B.Sc.
    President, CEO & Chairman
  • Mr. John M. Sprague CPA
    Mr. John M. Sprague CPA
    Chief Financial Officer
  • Mr. Michael Terrence Gibbs Esq.
    Mr. Michael Terrence Gibbs Esq.
    Senior VP, General Counsel & Company Secretary
  • Ms. Kelley J. Morgan
    Ms. Kelley J. Morgan
    Chief People Officer
  • Mr. Brett A. Giffin
    Mr. Brett A. Giffin
    Chief Commercial Officer
  • Dr. Roger  Smith Ph.D.
    Dr. Roger Smith Ph.D.
    Senior Vice President of Science Research & Development